TNF and rheumatoid arthritis: Anti-TNF therapy with specific TNF blocking antibodies such as infliximab, adalimumab, or golimumab is a well-established treatment for RA [18, 19], as these proteins interfere with inflammatory cascades and thereby prevent or slow down joint destruction very efficiently [20].